Immunoglobulin G Antibody Therapeutics Market Insights, Global Outlook and Forecast 2022-2028
Immunoglobulin G Antibody Therapeutics Market Insights, Global Outlook and Forecast 2022-2028
The research report on ‘Immunoglobulin G Antibody Therapeutics Market’ provides a workplan for stakeholders for the estimated timeframe of -. To elaborate, it offers valid predictions for the size, shares, and growth patterns of this domain over the projected timeline by assessing the past records and present business trends.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Immunoglobulin G Antibody, a protective protein produced by the immune system in response to the presence of a foreign substance. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.
The latest research study released by Market IntelliX evaluates market size and forecasts of Immunoglobulin G Antibody Therapeutics in Global, including the following market information:
Global Immunoglobulin G Antibody Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Immunoglobulin G Antibody Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
IgG1 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Immunoglobulin G Antibody Therapeutics include Roche, Abbvie, J & J, Bristol-Myers Squibb, Novartis, Merck, Alexion Pharmaceuticals, Takeda and Amgen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Immunoglobulin G Antibody Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Immunoglobulin G Antibody Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Immunoglobulin G Antibody Therapeutics Market Segment Percentages, by Type, 2021 (%)
IgG1
IgG4
Others
Global Immunoglobulin G Antibody Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Immunoglobulin G Antibody Therapeutics Market Segment Percentages, by Application, 2021 (%)
Autoimmune
Tumor
Others
Global Immunoglobulin G Antibody Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Immunoglobulin G Antibody Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunoglobulin G Antibody Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Immunoglobulin G Antibody Therapeutics revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Roche
Abbvie
J & J
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Immunoglobulin G Antibody Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immunoglobulin G Antibody Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immunoglobulin G Antibody Therapeutics Overall Market Size
2.1 Global Immunoglobulin G Antibody Therapeutics Market Size: 2021 VS 2028
2.2 Global Immunoglobulin G Antibody Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immunoglobulin G Antibody Therapeutics Players in Global Market
3.2 Top Global Immunoglobulin G Antibody Therapeutics Companies Ranked by Revenue
3.3 Global Immunoglobulin G Antibody Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Immunoglobulin G Antibody Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Immunoglobulin G Antibody Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immunoglobulin G Antibody Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Immunoglobulin G Antibody Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Immunoglobulin G Antibody Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Immunoglobulin G Antibody Therapeutics Market Size Markets, 2021 & 2028
4.1.2 IgG1
4.1.3 IgG4
4.1.4 Others
4.2 By Type - Global Immunoglobulin G Antibody Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Immunoglobulin G Antibody Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Immunoglobulin G Antibody Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Immunoglobulin G Antibody Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immunoglobulin G Antibody Therapeutics Market Size, 2021 & 2028
5.1.2 Autoimmune
5.1.3 Tumor
5.1.4 Others
5.2 By Application - Global Immunoglobulin G Antibody Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Immunoglobulin G Antibody Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Immunoglobulin G Antibody Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Immunoglobulin G Antibody Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Immunoglobulin G Antibody Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Immunoglobulin G Antibody Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Immunoglobulin G Antibody Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Immunoglobulin G Antibody Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Immunoglobulin G Antibody Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Immunoglobulin G Antibody Therapeutics Revenue, 2017-2028
6.3.2 US Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.3.3 Canada Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.3.4 Mexico Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Immunoglobulin G Antibody Therapeutics Revenue, 2017-2028
6.4.2 Germany Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.4.3 France Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.4.4 U.K. Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.4.5 Italy Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.4.6 Russia Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.4.8 Benelux Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Immunoglobulin G Antibody Therapeutics Revenue, 2017-2028
6.5.2 China Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.5.3 Japan Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.5.4 South Korea Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.5.6 India Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Immunoglobulin G Antibody Therapeutics Revenue, 2017-2028
6.6.2 Brazil Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.6.3 Argentina Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immunoglobulin G Antibody Therapeutics Revenue, 2017-2028
6.7.2 Turkey Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.7.3 Israel Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
6.7.5 UAE Immunoglobulin G Antibody Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.1.4 Roche Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Roche Key News
7.2 Abbvie
7.2.1 Abbvie Corporate Summary
7.2.2 Abbvie Business Overview
7.2.3 Abbvie Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.2.4 Abbvie Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Abbvie Key News
7.3 J & J
7.3.1 J & J Corporate Summary
7.3.2 J & J Business Overview
7.3.3 J & J Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.3.4 J & J Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2017-2022)
7.3.5 J & J Key News
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Corporate Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.4.4 Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Bristol-Myers Squibb Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.5.4 Novartis Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Novartis Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.6.4 Merck Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Merck Key News
7.7 Alexion Pharmaceuticals
7.7.1 Alexion Pharmaceuticals Corporate Summary
7.7.2 Alexion Pharmaceuticals Business Overview
7.7.3 Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.7.4 Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Alexion Pharmaceuticals Key News
7.8 Takeda
7.8.1 Takeda Corporate Summary
7.8.2 Takeda Business Overview
7.8.3 Takeda Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.8.4 Takeda Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Takeda Key News
7.9 Amgen
7.9.1 Amgen Corporate Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.9.4 Amgen Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Amgen Key News
7.10 Biogen
7.10.1 Biogen Corporate Summary
7.10.2 Biogen Business Overview
7.10.3 Biogen Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.10.4 Biogen Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Biogen Key News
7.11 UCB
7.11.1 UCB Corporate Summary
7.11.2 UCB Business Overview
7.11.3 UCB Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.11.4 UCB Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2017-2022)
7.11.5 UCB Key News
7.12 Eli Lilly and Company
7.12.1 Eli Lilly and Company Corporate Summary
7.12.2 Eli Lilly and Company Business Overview
7.12.3 Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.12.4 Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2017-2022)
7.12.5 Eli Lilly and Company Key News
7.13 AstraZeneca
7.13.1 AstraZeneca Corporate Summary
7.13.2 AstraZeneca Business Overview
7.13.3 AstraZeneca Immunoglobulin G Antibody Therapeutics Major Product Offerings
7.13.4 AstraZeneca Immunoglobulin G Antibody Therapeutics Revenue in Global Market (2017-2022)
7.13.5 AstraZeneca Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Immunoglobulin G Antibody Therapeutics Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|